Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Vaxin enrolls first patient in Phase I trial of HepTcell to treat hepatitis B virus By PBR Staff Writer
US-based biotechnology firm Vaxin has enrolled the first patient in a multi-center Phase I clinical trial of its immunotherapeutic compound, HepTcell (FP-02.2), for the treatment of people chronically infected with the hepatitis B virus (HBV).
Contract Research & Services > Clinical Trials > News
Inovio begins Phase I trial of INO-5150 DNA immunotherapy to treat prostate cancer By PBR Staff Writer
Inovio Pharmaceuticals has started a Phase I trial of its DNA immunotherapy, INO-5150, for the treatment of men with biochemically relapsed prostate cancer.
Contract Research & Services > Clinical Trials > News MonoSol Rx begins Phase IIa trial for Oral Insulin Film MonoSol Rx, the developer of PharmFilm drug delivery technology, with its partner Midatech Pharma, announced today that it has initiated a Phase 2a study for Midaform Insulin PharmFilm, MSL- 001, with the dosing of its first patient.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Heron begins second Phase II trial of HTX-011 to treat post-operative pain
By PBR Staff Writer
US-based biotechnology firm Heron Therapeutics has started a second Phase II clinical trial of HTX-011, which uses the company's Biochronomer drug delivery technology, for the treatment of post-operative pain.
Contract Research & Services > Clinical Trials > News
PRA Health Sciences Launches New Initiative To Bolster Workforce
PRA Health Sciences (PRA) (NASDAQ: PRAH) is looking to hire new talent. To help attract potential employees from around the world, PRA, a leading global contract research organization (CRO), is launching a new Candidate Experience initiative. Just as PRA is finding innovative ways to improve the clinical development process, it is also developing creative strategies to meet the ever-growing need to identify highly skilled clinical research employees.
Contract Research & Services > Clinical Trials > Press Releases
Lpath gets FDA nod to initiate Phase I lpathomab clinical trial
By PBR Staff Writer
The US Food and Drug Administration (FDA) has completed the review of an investigational new drug (IND) application for Lpath's lpathomab, an antibody targeting lysophosphatidic acid (LPA), and informed the company to initiate a Phase I clinical trial to evaluate the antibody.
Contract Research & Services > Clinical Trials > News
Tract Therapeutics completes Phase I safety trial using patient’s immune cells to prevent organ rejection
Tract Therapeutics announced that it has completed a first-in-human Phase I trial to study the safety of the use of a patient’s own immune system cells in kidney transplant recipients.
Contract Research & Services > Clinical Trials > News
BMS reports additional Phase IIa data for BMS-955176 to prevent maturation of HIV-1
Bristol-Myers Squibb Company announced additional Phase IIa proof-of-concept data for BMS-955176, a novel investigational agent designed to prevent the maturation of HIV-1.
Contract Research & Services > Clinical Trials > News
Alnylam begins Phase III APOLLO-OLE trial of patisiran to treat ATTR amyloidosis
By PBR Staff Writer
Alnylam Pharmaceuticals has started an open-label extension Phase III trial (abbreviated APOLLO-OLE) with patisiran, an investigational RNAi therapeutic targeting transthyretin (TTR) to treat TTR-mediated amyloidosis (ATTR amyloidosis) in patients with Familial Amyloidotic Polyneuropthy (FAP).
Contract Research & Services > Clinical Trials > News
Recro Pharma reports positive top-line results for Phase II trial of Dex-IN
Recro Pharma, a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of acute post operative pain, announced positive efficacy results in the Phase II clinical trial for Dex-IN, a proprietary intranasal formulation of dexmedetomidine, for the treatment of acute pain in adult patients undergoing bunionectomy surgery.
Contract Research & Services > Clinical Trials > News
BioLineRx to present successful Phase I/II trial results for new celiac treatment at International Celiac Disease Symposium
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will present positive safety results of its Phase 1/2 study for BL-7010, a novel polymer for the treatment of celiac disease, at the 16th International Celiac Disease Symposium (ICDS 2015), to take place from June 21-24 in Prague, Czech Republic.
Contract Research & Services > Clinical Trials > News
RegeneRx's GtreeBNT gets Korean approval for Phase IIb/III trial of RGN-259 in patients with DES
By PBR Staff Writer
US-based RegeneRx Biopharmaceuticals' licensee GtreeBNT has received approval from the Ministry of Food and Drug Safety (MFDS) in Korea to carry out a Phase IIb/III clinical trial of RGN-259 (GBT-201) in patients with dry eye syndrome (DES).
Contract Research & Services > Clinical Trials > News
BeiGene begins dosing in Phase Ib trial of BGB-283 to treat solid tumors
By PBR Staff Writer
China-based oncology firm BeiGene has started dosing in a Phase Ib clinical trial for BGB-283, a second generation B-RAF inhibitor, for the treatment of solid tumors.
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests